do-me/EUR-LEX huggingface dataset:
Political and Security Committee Decision (CFSP) 2022/2096 of 27 October 2022 on the appointment of the Combined Arms Training Commander for the European Union Military Assistance Mission in support of Ukraine (EUMAM Ukraine) (EUMAM Ukraine/1/2022)
Date: 2022-10-27
Institutions: Political and Security Committee
Subjects: EU military mission, Ukraine, appointment of members, military cooperation, military personnel, military training








L_2022281EN.01007101.xml










31.10.2022   


EN


Official Journal of the European Union


L 281/71








            POLITICAL AND SECURITY COMMITTEE DECISION (CFSP) 2022/2096
of 27 October 2022
         
on the appointment of the Combined Arms Training Commander for the European Union Military Assistance Mission in support of Ukraine (EUMAM Ukraine) (EUMAM Ukraine/1/2022)


THE POLITICAL AND SECURITY COMMITTEE,

Having regard to the Treaty on European Union, and in particular Article 38 thereof,


Having regard to Council Decision (CFSP) 2022/1968 of 17 October 2022 on a European Union Military Assistance Mission in support of Ukraine (EUMAM Ukraine) (1), and in particular Article 5(1) thereof,

Whereas:







(1)


On 17 October 2022, the Council adopted Decision (CFSP) 2022/1968 on a European Union Military Assistance Mission in support of Ukraine (EUMAM Ukraine).












(2)


Article 2(2) of Decision (CFSP) 2022/1968 provides that a multinational Combined Arms Training Command (CAT-C) is to be established at the operational level.












(3)


Pursuant to Article 5(1) of Decision (CFSP) 2022/1968, the Council authorised the Political and Security Committee to take the relevant decisions, in accordance with Article 38 of the Treaty on European Union, on the appointment of the EU Commanders for EUMAM Ukraine, including the Combined Arms Training Commander.












(4)


On 21 October 2022, the EU Mission Commander recommended the appointment of Major General Piotr TRYTEK as the Combined Arms Training Commander.












(5)


On 24 October 2022, the EU Military Committee supported that recommendation.












(6)


A decision should be taken on the appointment of Major General Piotr TRYTEK as the Combined Arms Training Commander for EUMAM Ukraine as from 27 October 2022,





HAS ADOPTED THIS DECISION:



Article 1
Major General Piotr TRYTEK is hereby appointed as the Combined Arms Training Commander for the European Union Military Assistance Mission in support of Ukraine (EUMAM Ukraine) as from 27 October 2022.


Article 2
This Decision shall enter into force on the date of its adoption.




Done at Brussels, 27 October 2022.


For the Political and Security Committee


The Chairperson

D. PRONK
            





(1)  
            OJ L 270, 18.10.2022, p. 85.
Political and Security Committee Decision (CFSP) 2022/2097 of 27 October 2022 on the appointment of the Special Training Commander for the European Union Military Assistance Mission in support of Ukraine (EUMAM Ukraine) (EUMAM Ukraine/2/2022)
Date: 2022-10-27
Institutions: Political and Security Committee
Subjects: EU military mission, Ukraine, appointment of members, military cooperation, military personnel, military training








L_2022281EN.01007201.xml










31.10.2022   


EN


Official Journal of the European Union


L 281/72








            POLITICAL AND SECURITY COMMITTEE DECISION (CFSP) 2022/2097
of 27 October 2022
         
on the appointment of the Special Training Commander for the European Union Military Assistance Mission in support of Ukraine (EUMAM Ukraine) (EUMAM Ukraine/2/2022)


THE POLITICAL AND SECURITY COMMITTEE,

Having regard to the Treaty on European Union, and in particular Article 38 thereof,


Having regard to Council Decision (CFSP) 2022/1968 of 17 October 2022 on a European Union Military Assistance Mission in support of Ukraine (EUMAM Ukraine) (1), and in particular Article 5(1) thereof,

Whereas:







(1)


On 17 October 2022, the Council adopted Decision (CFSP) 2022/1968 on a European Union Military Assistance Mission in support of Ukraine (EUMAM Ukraine).












(2)


Article 2(3) of Decision (CFSP) 2022/1968 provides that a Member State is to make available a multinational Special Training Command (ST-C) which is to command training activities on its soil.












(3)


Pursuant to Article 5(1) of Decision (CFSP) 2022/1968 the Council authorised the Political and Security Committee (PSC) to take the relevant decisions, in accordance with Article 38 of the Treaty on European Union, on the appointment of the EU Commanders for EUMAM Ukraine, including the Special Training Commander.












(4)


On 21 October 2022, the EU Mission Commander recommended the appointment of Lieutenant General Andreas MARLOW as the Special Training Commander.












(5)


On 24 October 2022, the EU Military Committee supported that recommendation.












(6)


A decision should be taken on the appointment of Lieutenant General Andreas MARLOW as the Special Training Commander for EUMAM Ukraine as from 27 October 2022,





HAS ADOPTED THIS DECISION:



Article 1
Lieutenant General Andreas MARLOW is hereby appointed as the Special Training Commander for the European Union Military Assistance Mission in support of Ukraine (EUMAM Ukraine) as from 27 October 2022.


Article 2
This Decision shall enter into force on the date of its adoption.




Done at Brussels, 27 October 2022.


For the Political and Security Committee


The Chairperson

D. PRONK
            





(1)  
            OJ L 270, 18.10.2022, p. 85.
Case T-657/22: Action brought on 27 October 2022 — moderne Stadt v EUIPO (DEUTZER HAFEN KÖLN)
Date: 2022-10-27
Institutions: General Court
Subjects: EU trade mark, building, consultancy, financial management, project management, property development, real estate business, registered trade mark, town planning, trade-mark law








C_2022472EN.01004801.xml










12.12.2022   


EN


Official Journal of the European Union


C 472/48






Action brought on 27 October 2022 — moderne Stadt v EUIPO (DEUTZER HAFEN KÖLN)
(Case T-657/22)
(2022/C 472/56)
Language of the case: German

Parties


Applicant: moderne Stadt Gesellschaft zur Förderung des Städtebaues und der Gemeindeentwicklung mbH (Cologne, Germany) (represented by: G. Simon and L. Daams, lawyers)

Defendant: European Union Intellectual Property Office (EUIPO)

Details of the proceedings before EUIPO


Trade mark at issue: EU word mark ‘DEUTZER HAFEN KÖLN’ — Application No 18 401 434

Contested decision: Decision of the Fifth Board of Appeal of EUIPO of 24 August 2022 in Case R 2196/2021-5

Form of order sought

The applicant claims that the Court should:






—


annul the contested decision;










—


order EUIPO to pay the costs.





Pleas in law







—


Infringement of Article 7(1)(c) read in conjunction with Article 7(2) of Regulation (EU) 2017/1001 of the European Parliament and of the Council;










—


Infringement of Article 7(1)(b) read in conjunction with Article 7(2) of Regulation (EU) 2017/1001 of the European Parliament and of the Council;










—


Infringement of the principle of equal treatment.
Case T-656/22: Action brought on 27 October 2022 — moderne Stadt v EUIPO (DEUTZER HAFEN)
Date: 2022-10-27
Institutions: General Court
Subjects: EU trade mark, building, consultancy, financial management, project management, property development, real estate business, registered trade mark, town planning, trade-mark law








C_2022472EN.01004702.xml










12.12.2022   


EN


Official Journal of the European Union


C 472/47






Action brought on 27 October 2022 — moderne Stadt v EUIPO (DEUTZER HAFEN)
(Case T-656/22)
(2022/C 472/55)
Language of the case: German

Parties


Applicant: moderne Stadt Gesellschaft zur Förderung des Städtebaues und der Gemeindeentwicklung mbH (Cologne, Germany) (represented by: G. Simon and L. Daams, lawyers)

Defendant: European Union Intellectual Property Office (EUIPO)

Details of the proceedings before EUIPO


Trade mark at issue: Application for the EU word mark DEUTZER HAFEN — Application No 18 316 145

Contested decision: Decision of the Fifth Board of Appeal of EUIPO of 24 August 2022 in Case R 2195/2021-5

Form of order sought

The applicant claims that the Court should:






—


annul the contested decision;










—


order EUIPO to pay the costs.





Pleas in law







—


Infringement of Article 7(1)(c) in conjunction with Article 7(2) of Regulation (EU) 2017/1001 of the European Parliament and of the Council;










—


Infringement of Article 7(1)(b) in conjunction with Article 7(2) of Regulation (EU) 2017/1001 of the European Parliament and of the Council;










—


Infringement of the principle of equal treatment.
Summary of European Commission Decisions on authorisations for the placing on the market for the use and/or for use of substances listed in Annex XIV to Regulation (EC) No 1907/2006 of the European Parliament and of the Council concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) (Published pursuant to Article 64(9) of Regulation (EC) No 1907/2006 (OJ L 396, 30.12.2006, p. 1.)) (Text with EEA relevance) 2022/C 412/07
Date: 2022-10-27
Institutions: Directorate-General for Internal Market, Industry, Entrepreneurship and SMEs, European Commission
Subjects: chemical product, health control, health risk, market approval, marketing standard, medical device








C_2022412EN.01001001.xml










27.10.2022   


EN


Official Journal of the European Union


C 412/10






Summary of European Commission Decisions on authorisations for the placing on the market for the use and/or for use of substances listed in Annex XIV to Regulation (EC) No 1907/2006 of the European Parliament and of the Council concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH)


(Published pursuant to Article 64(9) of Regulation (EC) No 1907/2006 (1))

(Text with EEA relevance)
(2022/C 412/07)

Decision granting an authorisation













Reference of the decision (2)



Date of decision


Substance name


Holder(s) of the authorisation


Authorisation number


Authorised use


Date of expiry of review period


Reasons for the decision




C(2022) 7405


20 October 2022


4-(1,1,3,3-Tetra methylbutyl)phenol, ethoxylated
(4-tert-OPnEO)
EC No: -, CAS No:-


Wallac Oy, Mustionkatu 6, 20750 Turku, Finland


REACH/22/39/0


Formulation of 4-tert-OPnEO into enhancement solutions and DELFIA standard and maintenance solutions used in In Vitro Diagnostic assays and RUO products as well as maintenance of instruments as a critical ingredient for detection process while measuring europium (or other lanthanide) content of the assay solution


4 January 2033


In accordance with Article 60(4) of Regulation (EC) No 1907/2006, the socio-economic benefits outweigh the risk to human health and the environment from the uses of the substance and there are no suitable alternative substances or technologies.




REACH/22/39/1


In enhancement solutions and DELFIA standard and maintenance solutions as a critical ingredient for detection process while measuring europium (or other lanthanide) content in In Vitro Diagnostic assays and RUO products or during maintenance of instruments






(1)  OJ L 396, 30.12.2006, p. 1.

(2)  The decision is available on the European Commission website at: Authorisation (europa.eu).
Council Decision (CFSP) 2022/2085 of 27 October 2022 amending Decision 2010/573/CFSP concerning restrictive measures against the leadership of the Transnistrian region of the Republic of Moldova
Date: 2022-10-27
Institutions: Council of the European Union
Subjects: EU restrictive measure, Moldova, economic sanctions, international sanctions




L_2022280EN.01004601.xml










28.10.2022   


EN


Official Journal of the European Union


L 280/46








            COUNCIL DECISION (CFSP) 2022/2085
of 27 October 2022
         
amending Decision 2010/573/CFSP concerning restrictive measures against the leadership of the Transnistrian region of the Republic of Moldova


THE COUNCIL OF THE EUROPEAN UNION,

Having regard to the Treaty on European Union, and in particular Article 29 thereof,


Having regard to the proposal from the High Representative of the Union for Foreign Affairs and Security Policy,

Whereas:







(1)


On 27 September 2010, the Council adopted Decision 2010/573/CFSP (1).












(2)


On the basis of a review of Decision 2010/573/CFSP, the restrictive measures against the leadership of the Transnistrian region of the Republic of Moldova should be extended until 31 October 2023. The Council will carry out a review of the situation with regard to the restrictive measures after 6 months.












(3)


Decision 2010/573/CFSP should therefore be amended accordingly,





HAS ADOPTED THIS DECISION:



Article 1
Article 4(2) of Decision 2010/573/CFSP is hereby replaced by the following:


‘2.   This Decision shall apply until 31 October 2023. It shall be kept under constant review. It shall be renewed or amended, as appropriate, if the Council deems that its objectives have not been met.’.




Article 2
This Decision shall enter into force on the day following that of its publication in the Official Journal of the European Union.




Done at Brussels, 27 October 2022.


For the Council


The President

M. BEK
            





(1)  Council Decision 2010/573/CFSP of 27 September 2010 concerning restrictive measures against the leadership of the Transnistrian region of the Republic of Moldova (OJ L 253, 28.9.2010, p. 54).
Case T-457/21: Order of the General Court of 27 October 2022 — Coulter Ventures v EUIPO — iWeb (R) (European Union trade mark — Opposition proceedings — Withdrawal of the opposition — No need to adjudicate)
Date: 2022-10-27
Institutions: General Court
Subjects: EU trade mark, clothing, footwear industry, registered trade mark, sports equipment, trade-mark law








C_2022482EN.01002001.xml










19.12.2022   


EN


Official Journal of the European Union


C 482/20






Order of the General Court of 27 October 2022 — Coulter Ventures v EUIPO — iWeb (R)
(Case T-457/21) (1)

(European Union trade mark - Opposition proceedings - Withdrawal of the opposition - No need to adjudicate)
(2022/C 482/29)
Language of the case: English

Parties


Applicant: Coulter Ventures LLC (Columbus, Ohio, United States) (represented by R. Dissmann, L. Jones and M. Lotz, lawyers)

Defendant: European Union Intellectual Property Office (EUIPO) (represented by M. Eberl and D. Gája, acting as Agents)

Other party to the proceedings before the Board of Appeal of EUIPO intervener before the General Court: iWeb GmbH (Berlin, Germany) (represented by T. Boddien, lawyer)

Re:

By its action under Article 263 TFEU, the applicant seeks annulment of the decision of the Fourth Board of Appeal of the European Union Intellectual Property Office (EUIPO) of 2 June 2021 (Case R 2789/2019-4).

Operative part of the order







1.


There is no longer any need to adjudicate on the action.










2.


Coulter Ventures LLC and iWeb GmbH shall bear their own costs and shall each pay half of those incurred by the European Union Intellectual Property Office (EUIPO).






(1)  OJ C 391, 27.9.2021.
Summary of European Commission Decisions on authorisations for the placing on the market for the use and/or for use of substances listed in Annex XIV to Regulation (EC) No 1907/2006 of the European Parliament and of the Council concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) (Published pursuant to Article 64(9) of Regulation (EC) No 1907/2006 (OJ L 396, 30.12.2006, p. 1.)) (Text with EEA relevance) 2022/C 412/06
Date: 2022-10-27
Institutions: Directorate-General for Internal Market, Industry, Entrepreneurship and SMEs, European Commission
Subjects: chemical compound, chemical product, health control, health risk, market approval, marketing standard, medical diagnosis








C_2022412EN.01000901.xml










27.10.2022   


EN


Official Journal of the European Union


C 412/9






Summary of European Commission Decisions on authorisations for the placing on the market for the use and/or for use of substances listed in Annex XIV to Regulation (EC) No 1907/2006 of the European Parliament and of the Council concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH)


(Published pursuant to Article 64(9) of Regulation (EC) No 1907/2006 (1))

(Text with EEA relevance)
(2022/C 412/06)

Decision granting an authorisation













Reference of the decision (2)



Date of decision


Substance name


Holder(s) of the authorisation


Authorisation number


Authorised use


Date of expiry of review period


Reasons for the decision




C(2022) 7381


20 October 2022


4-(1,1,3,3-Tetra methylbutyl)phenol, ethoxylated
(4-tert-OPnEO)
EC No: -, CAS No:-


Merck KGaA, Frankfurter Strasse, 64293 Darmstadt, Germany


REACH/22/34/0


As raw material for the manufacturing of GMP Triton® X-100 Emprove® Expert in accordance with International Pharmaceutical Excipients Council Europe standards


4 January 2033


In accordance with Article 60(4) of Regulation (EC) No 1907/2006, the socio-economic benefits outweigh the risk to human health and the environment from the uses of the substance and there are no suitable alternative substances or technologies.






(1)  OJ L 396, 30.12.2006, p. 1.

(2)  The decision is available on the European Commission website at: Authorisation (europa.eu).
Non-opposition to a notified concentration (Case M.10712 – APOLLO MANAGEMENT / TENNECO) (Text with EEA relevance) 2023/C 175/01
Date: 2022-10-27
Institutions: Directorate-General for Competition, European Commission
Subjects: economic concentration, merger control, motor vehicle industry, vehicle parts








C_2023175EN.01000101.xml










17.5.2023   


EN


Official Journal of the European Union


C 175/1






Non-opposition to a notified concentration
(Case M.10712 – APOLLO MANAGEMENT / TENNECO)
(Text with EEA relevance)
(2023/C 175/01)
On 27 October 2022, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:






—


in the merger section of the ‘Competition policy’ website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,










—


in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32022M10712. EUR-Lex is the online point of access to European Union law.






(1)  OJ L 24, 29.1.2004, p. 1.
Annual report on EU agencies for the financial year 2021 2022/C 412/09
Date: 2022-10-27
Institutions: European Court of Auditors
Subjects: EU office or agency, activity report, administration of the Institutions, auditing, budgetary control, financial control








C_2022412EN.01001201.xml










27.10.2022   


EN


Official Journal of the European Union


C 412/12






Annual report on EU agencies for the financial year 2021
(2022/C 412/09)
The European Court of Auditors will publish its annual report for the 2021 financial year on EU agencies, together with their replies, on 27 October 2022.
The report can be consulted directly or downloaded, from 17:00 on 27 October 2022, at the European Court of Auditors’ website:






 


https://www.eca.europa.eu/en/Pages/DocItem.aspx?did=62271
Case C-418/21: Judgment of the Court (Second Chamber) of 27 October 2022 (request for a preliminary ruling from the Oberlandesgericht Düsseldorf — Germany) — Orthomol pharmazeutische Vertriebs GmbH v Verband Sozialer Wettbewerb eV (Reference for a preliminary ruling — Food safety — Food — Regulation (EU) No 609/2013 — Article 2(2)(g) — Delegated Regulation (EU) 2016/128 — Food for special medical purposes — Other particular nutritional requirements — Food providing a general benefit for the patient — Distinction in relation to medicinal products)
Date: 2022-10-27
Institutions: Court of Justice
Subjects: dietary product, food safety, food supplement, human nutrition, medicinal product, nutritional disease, nutritional needs








C_2022472EN.01001902.xml










12.12.2022   


EN


Official Journal of the European Union


C 472/19






Judgment of the Court (Second Chamber) of 27 October 2022 (request for a preliminary ruling from the Oberlandesgericht Düsseldorf — Germany) — Orthomol pharmazeutische Vertriebs GmbH v Verband Sozialer Wettbewerb eV
(Case C-418/21) (1)

(Reference for a preliminary ruling - Food safety - Food - Regulation (EU) No 609/2013 - Article 2(2)(g) - Delegated Regulation (EU) 2016/128 - Food for special medical purposes - Other particular nutritional requirements - Food providing a general benefit for the patient - Distinction in relation to medicinal products)
(2022/C 472/22)
Language of the case: German

Referring court

Oberlandesgericht Düsseldorf

Parties to the main proceedings


Appellant: Orthomol pharmazeutische Vertriebs GmbH

Respondent: Verband Sozialer Wettbewerb eV

Operative part of the judgment

Article 2(2)(g) of Regulation (EU) No 609/2013 of the European Parliament and of the Council of 12 June 2013 on food intended for infants and young children, food for special medical purposes, and total diet replacement for weight control and repealing Council Directive 92/52/EEC, Commission Directives 96/8/EC, 1999/21/EC, 2006/125/EC and 2006/141/EC, Directive 2009/39/EC of the European Parliament and of the Council and Commission Regulations (EC) No 41/2009 and (EC) No 953/2009 and, in particular, the concept of ‘other medically determined nutrient requirements’,
must be interpreted as meaning that a product constitutes a food for special medical purposes if the disease results in increased or specific nutritional requirements which the food is intended to cover, such that it is not sufficient, for the purposes of such a qualification, that the patient derives a general benefit from the intake of that food because the substances that it contains counteract the disorder or alleviate its symptoms.


(1)  OJ C 471, 22.11.2021.
Statement by the Commission 2022/C 412/01
Date: 2022-10-27
Institutions: European Commission
Subjects: Internet, digital single market, digital technology, information society, innovation, micro-enterprise, provision of services, service, start-up








C_2022412EN.01000101.xml










27.10.2022   


EN


Official Journal of the European Union


C 412/1






Statement by the Commission
(2022/C 412/01)
The Commission acknowledges the importance of competitiveness, innovation and investment in digital services, in particular with regard to micro, small and medium sized enterprises and start-ups. For that purpose, the Commission is committed to facilitate compliance with the Digital Services Act by micro, small and medium sized enterprises and start-ups, notably through mobilising relevant programmes in favour of innovation, deployment of digital technologies and standardisation.